GE HealthCare

Photonova Spectra has achieved CE Mark. ✅ Following U.S. FDA 510(k) clearance and Japanese regulatory approval, this milestone expands access to our photon-counting CT with proprietary Deep Silicon detector technology across CE Mark–observing countries. For care teams navigating rising volumes and growing diagnostic complexity, it's engineered to deliver clarity and efficiency in the same scan.

Say hello to the newest family in cardiovascular ultrasound. 👋 At #ESCCongress, we're introducing Vivid Explorer*, Vivid Advanced* and Vivid Focus* to the Vivid portfolio—each purposefully designed for a different corner of cardiology care, from advanced diagnostics to focused, everyday exams. What they share is what the Vivid name has always stood for: high performance, precision and AI-powered intelligence. *Vivid Explorer, Vivid Advanced and Vivid Focus are CE Marked and 510(k) pending with the U.S. FDA and not available for sale in the U.S.

Utah just got a major upgrade in cancer and heart care. Intermountain Health Medical Center in Murray is now the first hospital in Utah—and only the second in the U.S.—to use our SIGNA™ Sprint Elite* MRI, an AI-powered system delivering clearer images in less time. Faster scans may mean shorter wait times and more patients seen. Cardiac patients may no longer need to repeatedly hold their breath during exams. "This new machine isn’t just giving us exceptional images but is putting patient comfort as a major focus and we’re already seeing a difference" said Amy Warnick, MRI coordinator at Intermountain Medical Center. *SIGNA Sprint Elite is a premium configuration of SIGNA Sprint.

Turns out innovation runs in the family. 💡 During the 2026 GE HealthCare STEAM Camp at Mount Mary, 20 camp participants spent the week exploring science, technology, engineering, arts, and mathematics through hands-on activities—such as create your own fidget and building a bird feeder—designed to spark curiosity and build confidence. Our goal is simple: to help young learners explore STEAM activities. By providing opportunities for hands-on learning and discovery, we hope to spark interests that can shape future educational and career journeys. Thank you to Mount Mary University and to our colleagues who shared their time and expertise throughout the week!

Interventional radiology just took another significant step forward. 🌟 We’re proud to celebrate the growing use of Allia Moveo across leading interventional suites: • A world first: Allia Moveo arrives at UZ Brussel marking first-ever installation in interventional radiology suite • Expanding what’s possible: Image Guided Therapy, LLC in Denver becomes one of the first office based labs with Allia Moveo in the world More patients are now being treated with Allia Moveo, bringing this innovation from milestone to meaningful clinical impact. Thank you to the teams at UZ Brussel and Image Guided Therapy for your trust and collaboration. Together, we’re advancing image guiding solutions and bringing a high-performance system with exceptional image quality to interventional suites around the world. Here's to shaping the future of interventional radiology together. 🙌

Speed and safety aren't a trade-off—they're a standard. Following a request to accelerate to several hospitals from the President of Indonesia, we supported the arrival of critical supplies in just 3 days—from request to delivery. Thank you to our Indonesia team for the speed and coordination that made it happen. 💜

About 40% of women have dense breasts. Mammography may miss 1 in 3 cancers in this tissue type. That's where Invenia ABUS Prime* and ABUS StreamVue* comes in—designed to support supplemental screening for women with dense breasts, with AI-driven 3D ultrasound and remote reading capabilities needed to scale across enterprise imaging networks. One of the first U.S. installations of Invenia ABUS Prime is now live in Los Angeles at BeSound, a center focused on expanding access to supplemental breast imaging for women, including those with dense breast tissue and women under 40, an age group with rising breast cancer rates. BeSound also plans to support efforts to make breast imaging research more representative of the diverse communities it serves. Take a look at how they’re using Invenia ABUS Prime to build a breast health experience that puts women's needs first. *Invenia ABUS Prime is FDA Premarket Approved and CE Marked. ABUS StreamVue is FDA 510(k) cleared and CE Marked.

An estimated 97% of hospital data goes unused—not for lack of data, but because it's siloed across disconnected systems and specialties. The next leap in healthcare AI isn't another standalone tool. It's orchestration: connecting people, data, and technology. So, clinicians get the right information at the right moment, and patients receive more precise care. In his latest byline, Philip Rackliffe, President and CEO, Advanced Imaging Solutions, shares his perspective on how orchestrated AI can help unlock the full potential of healthcare data.

Thirty years ago, Community Service Day began as a local tradition. This July, it became a global moment of service. 🌍 Across the world, colleagues came together to support education, food access, environmental sustainability and stronger communities. Grateful to Milwaukee Public Schools, our original partner, for helping start 30 years of impact—and counting.

Lung cancer is responsible for roughly one in five cancer deaths, the leading cause of cancer-related deaths worldwide. But when it's detected early, outcomes can change dramatically. Every lung nodule represents an important clinical question: What comes next? Getting that answer sooner takes advanced imaging, AI-powered workflow tools, and strong partnerships. This #WorldLungCancerDay, we're recognizing the clinicians and innovators working to help enable earlier and more informed decisions across the lung cancer care pathway. Because meaningful progress happens when technology and clinical expertise come together.